Splenic Marginal Zone Lymphoma
Showing NaN - NaN of 7
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +20 more
- panobinostat
- +6 more
-
Scottsdale, Arizona
- +1 more
May 6, 2022
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +18 more
- everolimus
- +6 more
-
Scottsdale, Arizona
- +1 more
Sep 28, 2020
Anaplastic Large Cell Lymphoma, Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Mature T-Cell and
Completed
- Anaplastic Large Cell Lymphoma
- +12 more
- Laboratory Biomarker Analysis
- Tipifarnib
-
Iowa City, Iowa
- +1 more
Apr 3, 2020
Cutaneous B-cell Non-Hodgkin Lymphoma, MALT, Nodal Marginal Zone B-cell Lymphoma Trial in Rochester (biological, procedure,
Completed
- Cutaneous B-cell Non-Hodgkin Lymphoma
- +15 more
- dendritic cell vaccine therapy
- +6 more
-
Rochester, MinnesotaMayo Clinic
Jan 13, 2020
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Nodal Marginal Zone Lymphoma, Recurrent Grade 1
Completed
- Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
- +8 more
- Bortezomib
- +5 more
-
Scottsdale, Arizona
- +1 more
Apr 4, 2019
MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Rochester (rituximab, yttrium Y 90
Terminated
- Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
- +8 more
- rituximab
- +4 more
-
Rochester, MinnesotaMayo Clinic
Jul 9, 2018
MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Rochester (biological, other,
Completed
- Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
- +6 more
- rituximab
- +4 more
-
Rochester, MinnesotaNorth Central Cancer Treatment Group
Aug 23, 2013